Atomoxetine
Atomoxetine is a drug approved for the treatment of attention-deficit hyperactivity disorder (ADHD).
AtomoxetineAttention deficit hyperactivity disorder managementAntidepressantNorepinephrine reuptake inhibitorNorepinephrineDiscovery and development of dual serotonin and norepinephrine reuptake inhibitorsNorepinephrine transporter5-Choice Serial Reaction Time TaskTreatment of Tourette syndromeSerotonin–norepinephrine–dopamine reuptake inhibitorAdult attention deficit hyperactivity disorderAttention deficit hyperactivity disorderPhenyltropaneNisoxetineOff-label useAdderallHepatitisCYP2D6Annual pharmaceutical drug salesTalegenes Attention Training
Share this!